Tissue-resident memory T cells at the center of immunity to solid tumors

Nature Immunology

Volumn 19, Issue 6, 2018, Pages 538-546

  Amsen, Derk ^a   Van Gisbergen, Klaas P J M ^a   Hombrink, Pleun ^a   Van Lier, Rene A W ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE;

CELL METABOLISM; HUMAN; MEMORY T LYMPHOCYTE; NONHUMAN; PRECURSOR; PRIORITY JOURNAL; PROTEIN FUNCTION; RESPIRATORY EPITHELIUM; REVIEW; SOLID MALIGNANT NEOPLASM; TUMOR IMMUNITY; ANIMAL; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MOUSE; NEOPLASM; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; HUMANS; IMMUNOLOGIC MEMORY; MICE; NEOPLASMS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 85047110508     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/s41590-018-0114-2     Document Type: Review

References (124)

1. Becht, E., Giraldo, N. A., Dieu-Nosjean, M. C., Sautès-Fridman, C. & Fridman, W. H. Cancer immune contexture and immunotherapy. Curr. Opin. Immunol. 39, 7-13 (2016).
2. Fridman, W. H., Pagès, F., Sautès-Fridman, C. & Galon, J. The immune contexture in human tumours: impact on clinical outcome. Nat. Rev. Cancer 12, 298-306 (2012).
3. Chen, D. S. & Mellman, I. Elements of cancer immunity and the cancer-immune set point. Nature 541, 321-330 (2017).
4. Lim, W. A. & June, C. H. The principles of engineering immune cells to treat cancer. Cell 168, 724-740 (2017).
5. Dadi, S. & Li, M. O. Tissue-resident lymphocytes: sentinel of the transformed tissue. J. Immunother. Cancer 5, 41 (2017).
6. + lung-resident memory T cells. Nat. Immunol. 17, 1467-1478 (2016).
7. Kumar, B. V. et al. Human tissue-resident memory T cells are defined by core transcriptional and functional signatures in lymphoid and mucosal sites. Cell Rep. 20, 2921-2934 (2017).
8. + T cells inhabit the human lungs. Mucosal Immunol. https://doi.org/10.1038/mi.2017.94 (2017).
9. Mueller, S. N. & Mackay, L. K. Tissue-resident memory T cells: local specialists in immune defence. Nat. Rev. Immunol. 16, 79-89 (2016).
10. Steinert, E. M. et al. Quantifying memory CD8 T cells reveals regionalization of immunosurveillance. Cell 161, 737-749 (2015).
11. RM cells are a separate memory T cell lineage.
12. Beura, L. K. et al. T cells in nonlymphoid tissues give rise to lymph-node-resident memory T cells. Immunity 48, 327-338 (2018).
13. Mackay, L. K. et al. Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes. Science 352, 459-463 (2016).
14. + T cells. Nat. Immunol. 14, 1285-1293 (2013).
15. Mackay, L. K. et al. Cutting edge: CD69 interference with sphingosine-1-phosphate receptor function regulates peripheral T cell retention. J. Immunol. 194, 2059-2063 (2015).
16. + T cells poised for cytotoxic function in human skin. Immunity 46, 287-300 (2017).
17. Gebhardt, T. et al. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat. Immunol. 10, 524-530 (2009).
18. Ray, S. J. et al. The collagen binding α1β1 integrin VLA-1 regulates CD8 T cell-mediated immune protection against heterologous influenza infection. Immunity 20, 167-179 (2004).
19. Goodison, S., Urquidi, V. & Tarin, D. CD44 cell adhesion molecules. Mol. Pathol. 52, 189-196 (1999).
20. McNamara, H. A. et al. Up-regulation of LFA-1 allows liver-resident memory T cells to patrol and remain in the hepatic sinusoids. Sci. Immunol. 2, eaaj1996 (2017).
21. + T cells are critical for protection against influenza A virus. Immunity 39, 939-948 (2013).
22. Wu, T. et al. Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection. J. Leukoc. Biol. 95, 215-224 (2014).
23. + T cells continuously patrol skin epithelia to quickly recognize local antigen. Proc. Natl Acad. Sci. USA 109, 19739-19744 (2012).
24. Wakim, L. M., Woodward-Davis, A. & Bevan, M. J. Memory T cells persisting within the brain after local infection show functional adaptations to their tissue of residence. Proc. Natl Acad. Sci. USA 107, 17872-17879 (2010).
25. + T cells trigger a state of tissue-wide pathogen alert. Science 346, 101-105 (2014).The study in ref. 25 reports an essential early role for TRM cells in the activation of the surrounding tissue to establish protection after re-infection.
26. Schenkel, J. M. et al. T cell memory. Resident memory CD8 T cells trigger protective innate and adaptive immune responses. Science 346, 98-101 (2014).
27. RM cells consists of the production of IFN-γ and the pro-inflammatory chemokines CCL3 and CCL4 to attract monocytes, neutrophils and circulating memory T cells.
28. McMaster, S. R., Wilson, J. J., Wang, H. & Kohlmeier, J. E. Airway-resident memory CD8 T cells provide antigen-specific protection against respiratory virus challenge through rapid IFN-γ production. J. Immunol. 195, 203-209 (2015).
29. + T cells with an intraepithelial phenotype upregulate cytotoxic function upon influenza infection in human lung. J. Clin. Invest. 121, 2254-2263 (2011).
30. Malik, B. T. et al. Resident memory T cells in the skin mediate durable immunity to melanoma. Sci. Immunol. 2, eaam6346 (2017).
31. + T cell fates via the graded expression of T-bet transcription factor. Immunity 27, 281-295 (2007).
32. + T cells and memory responses. Immunity 31, 283-295 (2009).
33. + T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity 31, 296-308 (2009).
34. Mackay, L. K. et al. T-box transcription factors combine with the cytokines TGF-β and IL-15 to control tissue-resident memory t cell fate. Immunity 43, 1101-1111 (2015).
35. + T cells during influenza viral infection. Immunity 41, 633-645 (2014).
36. Boddupalli, C. S. et al. ABC transporters and NR4A1 identify a quiescent subset of tissue-resident memory T cells. J. Clin. Invest. 126, 3905-3916 (2016).
37. RM cells share a transcriptional program to establish tissue residency.
38. van Gisbergen, K. P. et al. Mouse Hobit is a homolog of the transcriptional repressor Blimp-1 that regulates NKT cell effector differentiation. Nat. Immunol. 13, 864-871 (2012).
39. + T cells have a tissue resident memory T cell phenotype with reduced cytolytic capacity. Sci. Rep. 7, 6172 (2017).
40. high tissue-resident T cells in the human liver: sentinels for hepatotropic infection. J. Exp. Med. 214, 1567-1580 (2017).
41. Vieira Braga, F. A. et al. Blimp-1 homolog Hobit identifies effector-type lymphocytes in humans. Eur. J. Immunol. 45, 2945-2958 (2015).
42. + T cell differentiation. J. Clin. Invest. 120, 4077-4090 (2010).
43. Zaid, A. et al. Persistence of skin-resident memory T cells within an epidermal niche. Proc. Natl Acad. Sci. USA 111, 5307-5312 (2014).
44. + T cells with enhanced protective function. Immunity 40, 747-757 (2014).
45. Gaide, O. et al. Common clonal origin of central and resident memory T cells following skin immunization. Nat. Med. 21, 647-653 (2015).
46. Thome, J. J. et al. Spatial map of human T cell compartmentalization and maintenance over decades of life. Cell 159, 814-828 (2014).
47. + T cell differentiation revealed by single-cell RNA sequencing. Nat. Immunol. 18, 422-432 (2017).
48. Masopust, D. et al. Dynamic T cell migration program provides resident memory within intestinal epithelium. J. Exp. Med. 207, 553-564 (2010).
49. RM cells.
50. + central memory T cells. Immunity 41, 116-126 (2014).
51. RM cells but not that of circulating memory cells.
52. + mucosal T-cell differentiation and breast cancer rejection. Cancer Immunol. Res. 2, 487-500 (2014).
53. Mora, J. R. & von Andrian, U. H. T-cell homing specificity and plasticity: new concepts and future challenges. Trends Immunol. 27, 235-243 (2006).
54. Iijima, N. & Iwasaki, A. T cell memory. A local macrophage chemokine network sustains protective tissue-resident memory CD4 T cells. Science 346, 93-98 (2014).
55. + T-cell help. Nature 462, 510-513 (2009).
56. + TRM cells providing global skin immunity. Nature 483, 227-231 (2012).
57. + resident memory T cells shows tissue-autonomous recall responses that amplify secondary memory. Nat. Immunol. 19, 173-182 (2018).
58. Masopust, D., Vezys, V., Wherry, E. J., Barber, D. L. & Ahmed, R. Cutting edge: gut microenvironment promotes differentiation of a unique memory CD8 T cell population. J. Immunol. 176, 2079-2083 (2006).
59. Mackay, L. K. et al. Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation. Proc. Natl Acad. Sci. USA 109, 7037-7042 (2012).
60. Casey, K. A. et al. Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues. J. Immunol. 188, 4866-4875 (2012).
61. + T cells responding to infection. Nat. Immunol. 16, 406-414 (2015).
62. + memory T cells exhibit combined cluster-mediated retention and equilibration with the circulation. Nat. Commun. 7, 11514 (2016).
63. + T cell formation during viral infection. J. Exp. Med. 213, 951-966 (2016).
64. + T cells. J. Exp. Med. 213, 3075-3086 (2016).
65. Çuburu, N. et al. Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses. J. Clin. Invest. 122, 4606-4620 (2012).
66. Park, S. L. et al. Local proliferation maintains a stable pool of tissue-resident memory T cells after antiviral recall responses. Nat. Immunol. 19, 183-191 (2018).
67. Schenkel, J. M. et al. IL-15-independent maintenance of tissue-resident and boosted effector memory CD8 T cells. J. Immunol. 196, 3920-3926 (2016).
68. Slütter, B. et al. Dynamics of influenza-induced lung-resident memory T cells underlie waning heterosubtypic immunity. Sci. Immunol. 2, eaag2031 (2017).
69. Adachi, T. et al. Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma. Nat. Med 21, 1272-1279 (2015).
70. Surh, C. D. & Sprent, J. Homeostasis of naive and memory T cells. Immunity 29, 848-862 (2008).
71. Zhang, N. & Bevan, M. J. Transforming growth factor-β signaling controls the formation and maintenance of gut-resident memory T cells by regulating migration and retention. Immunity 39, 687-696 (2013).
72. Mohammed, J. et al. Stromal cells control the epithelial residence of DCs and memory T cells by regulated activation of TGF-β. Nat. Immunol. 17, 414-421 (2016).
73. + T cells form a front-line defense against malaria liver-stage infection. Immunity 45, 889-902 (2016).
74. Li, Y. et al. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 147, 629-640 (2011).
75. Furusawa, Y. et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446-450 (2013).
76. + T cells require increased concentrations of acetate induced by stress for optimal function. Immunity 44, 1312-1324 (2016).
77. Chang, C. H. et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153, 1239-1251 (2013).
78. Boddupalli, C. S. et al. Interlesional diversity of T cell receptors in melanoma with immune checkpoints enriched in tissue-resident memory T cells. JCI Insight 1, e88955 (2016).
79. + tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients. J. Immunol. 194, 3475-3486 (2015).
80. RM cells and survival rates.
81. Murray, T. et al. Very late antigen-1 marks functional tumor-resident CD8 T cells and correlates with survival of melanoma patients. Front. Immunol. 7, 573 (2016).
82. Webb, J. R., Milne, K. & Nelson, B. H. PD-1 and CD103 are widely coexpressed on prognostically favorable intraepithelial CD8 T Cells in human ovarian cancer. Cancer Immunol. Res. 3, 926-935 (2015).
83. Webb, J. R., Milne, K., Watson, P., Deleeuw, R. J. & Nelson, B. H. Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer. Clin. Cancer Res. 20, 434-444 (2014).
84. + CD8 T cells mediate beneficial anti-glioma immune responses. Cancer Immunol. Immunother. 63, 911-924 (2014).
85. + intraepithelial lymphocytes-a unique population in microsatellite unstable sporadic colorectal cancer. Eur. J. Cancer 39, 469-475 (2003).
86. + T cells that can be targeted for cancer immunotherapy. Oncotarget 7, 75130-75144 (2016).
87. Nizard, M. et al. Induction of resident memory T cells enhances the efficacy of cancer vaccine. Nat. Commun. 8, 15221 (2017).
88. + tumor infiltrating lymphocytes predict a favorable prognosis in urothelial cell carcinoma of the bladder. J. Urol. 194, 556-562 (2015).
89. Wang, Z. Q. et al. CD103 and intratumoral immune response in breast cancer. Clin. Cancer Res. 22, 6290-6297 (2016).
90. + tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma. Eur. J. Cancer 60, 1-11 (2016).
91. + tumor-infiltrating lymphocytes in pulmonary squamous cell carcinoma. Oncotarget 8, 13762-13769 (2017).
92. + T cells associated with prognostic benefit and therapy response in cervical cancer. OncoImmunology 6, e1338230 (2017).
93. Gabriely, G. et al. Targeting latency-associated peptide promotes antitumor immunity. Sci. Immunol. 2, eaaj1738 (2017).
94. Anz, D. et al. CD103 is a hallmark of tumor-infiltrating regulatory T cells. Int. J. Cancer 129, 2417-2426 (2011).
95. + T-cell-mediated tumor control in the genital tract. Clin. Cancer Res. 22, 657-669 (2016).
96. Boutet, M. et al. TGFβ signaling intersects with CD103 integrin signaling to promote T-lymphocyte accumulation and antitumor activity in the lung tumor microenvironment. Cancer Res. 76, 1757-1769 (2016).
97. Pickup, M., Novitskiy, S. & Moses, H. L. The roles of TGFβ in the tumour microenvironment. Nat. Rev. Cancer 13, 788-799 (2013).
98. + resident memory T cells in tumors. Cancer Res. 77, 7072-7082 (2017).
99. RM cell molecule CD103 has a function in killing tumor cells.
100. Le Floc'h, A. et al. Minimal engagement of CD103 on cytotoxic T lymphocytes with an E-cadherin-Fc molecule triggers lytic granule polarization via a phospholipase Cγ-dependent pathway. Cancer Res. 71, 328-338 (2011).
101. RM cells and elicits more-efficient anti-tumor immunity than does a systemic vaccine.
102. Mlecnik, B. et al. Functional network pipeline reveals genetic determinants associated with in situ lymphocyte proliferation and survival of cancer patients. Sci. Transl. Med. 6, 228ra37 (2014).
103. Dadi, S. et al. Cancer immunosurveillance by tissue-resident innate lymphoid cells and innate-like T cells. Cell 164, 365-377 (2016).
104. + T cells overcomes tumor-induced T-cell suppression and enhances immunotherapy in cancer. Cancer Immunol. Res. 2, 800-811 (2014).
105. + T cells and antitumor immunity by Notch signaling. Front. Immunol. 9, 101 (2018).
106. + T cell differentiation. Nat. Immunol. 15, 1143-1151 (2014).
107. RM cells rely on uptake of fatty acids for their energy metabolism rather than on glucose, which is of low abundance in several tissues.
108. + T cell fatty acid catabolism within a metabolically challenging tumor microenvironment increases the efficacy of melanoma immunotherapy. Cancer Cell 32, 377-391 (2017).
109. Buck, M. D., Sowell, R. T., Kaech, S. M. & Pearce, E. L. Metabolic instruction of immunity. Cell 169, 570-586 (2017).
110. Parker, B. S., Rautela, J. & Hertzog, P. J. Antitumour actions of interferons: implications for cancer therapy. Nat. Rev. Cancer 16, 131-144 (2016).
111. Wang, W. et al. Effector T cells abrogate stroma-mediated chemoresistance in ovarian cancer. Cell 165, 1092-1105 (2016).
112. Zitvogel, L., Galluzzi, L., Smyth, M. J. & Kroemer, G. Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. Immunity 39, 74-88 (2013).
113. + dendritic cell spatial and functional cooperativity to optimize priming. Immunity 46, 205-219 (2017).
114. + dendritic cells in cytotoxic T cell immunity. Science 322, 1097-1100 (2008).
115. + dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma. Cancer Cell 30, 324-336 (2016).
116. Spranger, S., Bao, R. & Gajewski, T. F. Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity. Nature 523, 231-235 (2015).
117. Spranger, S., Dai, D., Horton, B. & Gajewski, T. F. Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy. Cancer Cell 31, 711-723 (2017).
118. Reuben, A. et al. Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma. NPJ Genom. Med. 2, 10 (2017).
119. Glasner, A. et al. NKp46 receptor-mediated interferon-γ production by natural killer cells increases fibronectin 1 to alter tumor architecture and control metastasis. Immunity 48, 107-119 (2018).
120. Stary, G. et al. VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells. Science 348, aaa8205 (2015).
121. Dalgleish, A. G. Therapeutic cancer vaccines: why so few randomised phase III studies reflect the initial optimism of phase II studies. Vaccine 29, 8501-8505 (2011).
122. Nizard, M., Roussel, H. & Tartour, E. Resident memory T cells as surrogate markers of the efficacy of cancer vaccines. Clin. Cancer Res. 22, 530-532 (2016).
123. Geukes Foppen, M. H., Donia, M., Svane, I. M. & Haanen, J. B. Tumor-infiltrating lymphocytes for the treatment of metastatic cancer. Mol. Oncol. 9, 1918-1935 (2015).
124. Hinrichs, C. S. & Rosenberg, S. A. Exploiting the curative potential of adoptive T-cell therapy for cancer. Immunol. Rev. 257, 56-71 (2014).